ARCHIVES

GAO Suggests No Limit On Indirect Costs But Ceiling On Total Costs

This article is from The Cancer Letter archive.

Vol. 05 No. 36 | September 7, 1979

Download PDF Visit The Full Archive

Related Articles

BMS, Exelixis To Collaborate On Drug Development.

July 27, 2001

L-PAM Benefit To Post-Menopausal Patients Challenged

October 29, 1976

Cancer Panel Urges Improved Funding For Basic Science

June 16, 1995

President, Congress, Cancer Letter Take Off

August 22, 1986

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

July 27, 2012

Study Disproves “Old Saw,” Finds Life No Worse for Cancer Patients

December 3, 1982